Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.35 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CISD2 | Q8N5K1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29372058 | 0.86 | GAA (0.39) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL58579 | 0.86 | GAA (0.39) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL5145424 | 0.83 | KMT2A (0.37) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL11062242 | 0.81 | GAA (0.40) | KMT2AGAATAS1R3TAS1R1TAS1R2 | |
| SCHEMBL5145413 | 0.79 | LMNA (0.45) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL11058064 | 0.79 | CA12 (0.44) | KMT2AMEN1HPGDGAATAS1R3 | |
| SCHEMBL11059161 | 0.77 | RAPGEF4 (0.37) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL28510079 | 0.76 | HTT (0.38) | KMT2AMEN1HPGDLMNASMN1; SMN2 | |
| SCHEMBL6469382 | 0.75 | S1PR4 (0.43) | KMT2AMEN1SMN1; SMN2GAA | |
| SCHEMBL29759580 | 0.74 | LMNA (0.36) | KMT2AMEN1HPGDLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7776109-B2 | Method for producing acylphosphine oxide solids | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-17 | — | — | US | disclosed |
| US-20070167653-A1 | Method for producing acylphosphine oxide solids | BASF AKIENGESELLSCHAFT (DE) | 2007-07-19 | — | — | US | disclosed |
| US-4447520-A | PHOTOINITIATOR FOR PHOTOPOLYMERIZATION | BASF AKTIENGESELLSCHAFT (DE) | 1984-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167653-A1 | Method for producing acylphosphine oxide solids | AGPAT5, PHOSPHO1, AGPS | KMT2A 2152/4885MEN1 1381/4885HPGD 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.